- Home
- MPX vs AMRN Comparison
MPX vs AMRN Comparison
Compare MPX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPX | AMRN |
|---|---|---|
| Founded | 1965 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 264.3M | 304.6M |
| IPO Year | 2000 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MPX | AMRN |
|---|---|---|
| Price | $7.46 | $14.54 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 32.8K | ★ 36.0K |
| Earning Date | 01-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.40% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $244,419,000.00 | $181,104,000.00 |
| Revenue This Year | $13.72 | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | $23.66 | ★ N/A |
| Revenue Growth | 3.32 | ★ 39.22 |
| 52 Week Low | $6.83 | $8.84 |
| 52 Week High | $10.08 | $20.90 |
Technical Indicators
Market Signals| Indicator | MPX | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 46.02 |
| Support Level | $6.96 | $14.39 |
| Resistance Level | $7.62 | $16.95 |
| Average True Range (ATR) | 0.17 | 0.53 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 91.07 | 59.20 |
Price Performance
Historical ComparisonAbout MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.